Drug
Combination OF Varlilumab And Nivolumab
Combination OF Varlilumab And Nivolumab: highest development phase Phase 1/2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Combination of varlilumab and nivolumab NCT02335918 | Phase 1/2 | Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
Latest
No recent events.
Follow Combination OF Varlilumab And Nivolumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.